Financials
Financial year 2023
Worth noting
- Little cash and receivables against the short-term debts.
Revenue
€ 1,107.9 million
Profit
Caution€ -2.7 million
Debts
High€ 198.3 million
PHOENIX Pharma Belgium from Sint-Lambrechts-Woluwe, company number BE0425353116, closed financial year 2023 with a result of € -2.7 million after tax. For that financial year PHOENIX Pharma Belgium recorded revenue of € 1,107.9 million and equity of € 18.8 million. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 11, 2023.
What happened at PHOENIX Pharma Belgium?
What happened at PHOENIX Pharma Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Philippe LACROIX stepped down as director. NBB
- New annual accounts for financial year 2023: loss of € 2.7 million. Source: NBB ↗
- Arnaud Berken stepped down as director. NBB
- Hubert OLIVIER stepped down as director. NBB
- Hubert OLIVIER became a director. NBB
- Philippe LACROIX became a director. NBB
- Arnaud Berken became a director. NBB
- New establishment in Gent. KBO
In short
Paid € 517,582 in corporate taxes since 2023.
Pays suppliers within 46 days on average.
A new publication or filing at PHOENIX Pharma Belgium? We notify you, reason included.
Follow PHOENIX Pharma BelgiumNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by PHOENIX Belgium (100%).
Directors
According to the 2023 annual accounts
since 2021 · until 2022
since 2021 · until 2024
since 2020 · until 2023
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Emile Vanderveldelaan 82
1200 Sint-Lambrechts-Woluwe
Hendriklei 69
2660 Antwerpen
Active since 1 April 1967
Industrieweg (B) 106
3980 Tessenderlo-Ham
Active since 1 April 1967
Chemin de la Reconversion(H-G) 15
7110 La Louvière
Active since 23 August 2005
Avenue de l'Energie 33
4432 Ans
Active since 1 November 2010
Avenue Pasteur 2
1300 Wavre
Active since 1 September 2014
Cokeriestraat 5
1850 Grimbergen
Active since 1 September 2015
Marthe Versichelenstraat 1
9052 Gent
Active since 1 October 2019
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0425.353.116
- VAT number
- BE 0425.353.116
- Registered office
- Emile Vanderveldelaan 82, 1200 Sint-Lambrechts-Woluwe
- Names & denominations
- PHOENIX Pharma Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 December 1983
- Peppol
- Active · Active since 17 Dec 2024
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Vervaardiging van geneesmiddelen